Inventor · disambiguated record
Jean-François Prost
Also filed as: PROST JEAN-FRANCOIS · PROST JEAN-FRANÇOIS
4 granted patents·8 pending applications·18 citations·filing 2005–2021
70Inventor score
Files withGAMAMABS PHARMA7CHENOU CATHERINE1DE ROMEUF CHRISTOPHE1EXELIXIS INC1LAB FRANCAIS DU FRACTIONNEMENT1
Top patents by PatentIndex Score
12 records- 0190US9873745B2Antibody method for treatment of a disease in which the target cells are cells which express CD20LAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 23, 2018·7 cites·17 claims
- 0285US9234045B2Monoclonal antibody directed against CD20 antigenDE ROMEUF CHRISTOPHE·Filed 2005·Granted Jan 12, 2016·10 cites·12 claims
- 0363US10509035B2Antibodies, antibody drug conjugates and methods of useGAMAMABS PHARMA·Filed 2016·Granted Dec 17, 2019·1 cites·9 claims
- 0456US2022144959A1Amhrii-binding compounds for preventing or treating cancersGAMAMABS PHARMA·Filed 2021·Application pending·0 cites
- 0545US2023348607A1Amh-competitive antagonist antibodyEXELIXIS INC·Filed 2020·Application pending·0 cites
- 0643US2009175789A1Antibody raised against the ldl receptorLFB BIOTECHNOLOGIES·Filed 2006·Application pending·0 cites
- 0740US2023001006A1Amhrii-binding antibody drug conjugates and their use thereof in the treatment of cancersGAMAMABS PHARMA·Filed 2020·Application pending·0 cites
- 0839US2019367625A1Amhrii-binding compounds for preventing or treating cancersGAMAMABS PHARMA·Filed 2019·Application pending·0 cites
- 0933US11001634B2Anti-human-HER3 antibodies and uses thereofGAMAMABS PHARMA·Filed 2016·Granted May 11, 2021·0 cites·21 claims
- 1032US2013259801A1Serum amyloid p proteinCHENOU CATHERINE·Filed 2011·Application pending·0 cites
- 1132US2020148777A1Cancer-associated immunosuppression inhibitorGAMAMABS PHARMA·Filed 2018·Application pending·0 cites
- 1231US2023227566A1Amhrii-binding compounds for preventing or treating lung cancersGAMAMABS PHARMA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-François Prost files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →